Holding(s) in Company | 28-Aug-2025 | 12:00 | RNS |
Change of Auditor | 08-Aug-2025 | 07:00 | RNS |
Grant of Options and PDMR Dealing | 04-Jun-2025 | 07:00 | RNS |
Result of AGM | 02-Jun-2025 | 13:32 | RNS |
Non-Executive Director Board Change | 02-Jun-2025 | 07:00 | RNS |
Director/PDMR Dealing | 21-May-2025 | 07:00 | RNS |
Arecor Partnership with Skye Bioscience | 19-May-2025 | 07:00 | RNS |
Director Dealing | 14-May-2025 | 14:37 | RNS |
Arecor sells rights to non-Ogluo® products | 08-May-2025 | 07:00 | RNS |
Posting of 2024 Annual Report and Notice of AGM | 06-May-2025 | 16:42 | RNS |
Grant of Options and PDMR Dealing | 23-Apr-2025 | 07:00 | RNS |
Final results for 2024 | 22-Apr-2025 | 07:00 | RNS |
Notice of Results | 10-Apr-2025 | 07:00 | RNS |
Collaboration with global pharmaceutical partner | 26-Mar-2025 | 07:00 | RNS |
Arecor partnership with biopharmaceutical company | 12-Mar-2025 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 63.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 86.50p |
52 Week Low | 38.00p |
Volume | 3,022 |
Shares Issued | 37.76m |
Market Cap | £23.98m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
08:02 | 2 @ 65.00p |
08:02 | 20 @ 62.00p |
08:00 | 3,000 @ 63.14p |
CEO | Sarah Jennifer Howell |
CFO | David Ellam |
You are here: research